On June 18, Merck fell 3.01% in regular trading, trading at $111.89/share, with Turnover of $539 million.
Within the Pharmacy sector where Merck belongs, the overall sector showed broad-based weakness. Among individual stocks, Eli Lilly down 1.93%, Johnson & Johnson down 2.52%, Pfizer down 3.72%, Bristol-Myers Squibb down 2.98%, Zoetis up 0.83%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)